Molnupiravir blocks Covid virus within 24 hrs: Study
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A new study published in Nature Microbiology eveals that a new antiviral drug has been designed which successfully suppresses the SARS-CoV-2 virus and inhibits transmission within 24 hours.

The researchers claim that MK-4482/EIDD-2801 or molnupiravir is the first orally available drug to quickly block SARS-CoV-2 and has the potential of being ground-breaking. They had developed an orally deliverable ribonucleoside analogue inhibitor that worked against the influenza viruses and witnessing its efficacy, they decided to repurpose the drug for use against SARS-CoV-2.

The drug, molnupiravir, is now in phase II/III clinical trials but has been tested to be successful against the virus in ferrets. Once the ferrets were treated with molnupiravir it was administered twice daily some very promising results were found.

Benefits of molnupiravir are it can stop the progress of the infection and prevent severe disease and adverse outcomes. It can reduce the total duration of the infection and it can rapidly control local outbreaks if delivered to populations that have a high-transmissibility.

Source:
https://www.firstpost.com/health/new-antiviral-oral-drug-molnupiravir-completely-suppresses-coronavirus-transmission-within-24-hours-in-ferrets-claims-study-9080901.html
B●●●u S●●●●a and 39 others like this38 shares
Like
Comment
Share
Dr. J●i B●●●●i
Dr. J●i B●●●●i Obstetrics and Gynaecology
Is it available in India?
Dec 7, 2020Like
Dr. A●●●●r C●●●●●●●●●●●r
Dr. A●●●●r C●●●●●●●●●●●r Internal Medicine
Provide Drug details
Dec 11, 2020Like